Similar articles

• Characterization of biotin interference in 21 Vitros 5600 immunoassays and risk mitigation for patient safety at a large academic medical center.

  Stieglitz HM, Korpi-Steiner N. Stieglitz HM, et al. Clin Biochem. 2020 Jan;75:53-61. doi: 10.1016/j.clinbiochem.2019.09.006. Epub 2019 Oct 31. Clin Biochem. 2020. PMID: 31677994
• Biotin Interference in Clinical Immunoassays: A Cause for Concern.

  Holmes EW, Samarasinghe S, Emanuele MA, Meah F. Holmes EW, et al. Arch Pathol Lab Med. 2017 Nov;141(11):1459-1460. doi: 10.5858/arpa.2017-0107-LE. Arch Pathol Lab Med. 2017. PMID: 29072950 No abstract available.
• Discordant Analytical Results Caused by Biotin Interference on Diagnostic Immunoassays in a Pediatric Hospital.

  Ali M, Rajapakshe D, Cao L, Devaraj S. Ali M, et al. Ann Clin Lab Sci. 2017 Sep;47(5):638-640. Ann Clin Lab Sci. 2017. PMID: 29066495
• BIOTIN INTERFERENCE WITH ROUTINE CLINICAL IMMUNOASSAYS: UNDERSTAND THE CAUSES AND MITIGATE THE RISKS.

  Samarasinghe S, Meah F, Singh V, Basit A, Emanuele N, Emanuele MA, Mazhari A, Holmes EW. Samarasinghe S, et al. Endocr Pract. 2017 Aug;23(8):989-998. doi: 10.4158/EP171761.RA. Epub 2017 May 23. Endocr Pract. 2017. PMID: 28534685 Review.
• Biotin interference in immunoassays based on biotin-strept(avidin) chemistry: An emerging threat.

  Luong JHT, Male KB, Glennon JD. Luong JHT, et al. Biotechnol Adv. 2019 Sep-Oct;37(5):634-641. doi: 10.1016/j.biotechadv.2019.03.007. Epub 2019 Mar 11. Biotechnol Adv. 2019. PMID: 30872068 Review.